DKCM
IMPL

Davidson Kempner Capital Management’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Davidson Kempner Capital Management’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-230,238
Closed -$2.02M – 604
2021
Q2 		$2.02M Buy
+230,238
New +$2.75M 0.02% 343

Other funds holding IMPL

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
NVPX
Norwest Venture Partners XIV Palo Alto, California $60.4M AUM 9.56% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Davidson Kempner Capital Management's IMPL Position: Q3 2021 in Review

Davidson Kempner Capital Management sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q3 2021, closing a stake of 230,238 shares — an estimated $2.02M sold.

Davidson Kempner Capital Management first reported a position in IMPL in Q2 2021 and held it in 1 quarter. The position peaked at $2.02M in Q2 2021. 44 funds tracked by Wall St. Rank hold IMPL as of Q3 2021.

  • Davidson Kempner Capital Management reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 230,238 Impel Pharmaceuticals Inc. Common Stock shares in Q3 2021, an estimated $2.02M.
  • Davidson Kempner Capital Management first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Impel Pharmaceuticals Inc. Common Stock position peaked at $2.02M in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q3 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.